Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-10-26

Midlife time-restricted feeding preserves skeletal muscle insulin responsiveness and function during aging.

Raz Ben-David, Nikita Sarvin, Eli Carmeli, Nitsan Dahan, Tomer Shlomi, Shenhav Shemer

Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel.Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel. · pubmed

Abstract

Primary sarcopenia, the progressive loss of skeletal muscle mass and function during aging, is partly driven by anabolic resistance, a reduced ability of aged muscle to activate protein synthesis in response to nutrients and hormones. We compared 12-wk time-restricted feeding (TRF) and alternate-day fasting (ADF) interventions initiated at 3, 12, 15, or 18 mo of age in male C57BL/6J mice (analyzed at 6, 15, 18, or 21 mo, respectively). The effects of intermittent fasting on skeletal muscle were strongly age-dependent. Midlife (15 mo of age) TRF preserved lean mass, improved glucose tolerance, and increased insulin-stimulated glucose uptake in isolated muscle, whereas ADF induced broader metabolic remodeling but was associated with lean-tissue loss when initiated later in life. Muscle aging was accompanied by reduced membrane abundance of insulin receptor-plakoglobin-dystrophin glycoprotein complex (DGC) signaling assembly. However, midlife TRF was associated with greater abundance of these protein modules and enhanced postprandial AKT signaling. These findings identify midlife as a responsive window for nutritional timing interventions and link improved muscle insulin responsiveness and maintenance with diet-associated differences in sarcolemmal protein abundance and organization, although targeted perturbation studies are required to establish causality.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Midlife time-restricted feeding preserves skeletal muscle insulin responsiveness and function by maintaining the abundance and organization of sarcolemmal insulin receptor signaling complexes. This is relevant because it identifies a specific, modifiable nutritional intervention (TRF) and a critical temporal window (midlife) that can mitigate anabolic resistance, a key driver of sarcopenia and metabolic decline, thereby addressing a root cause of age-related functional loss rather than just treating symptoms.

Author of this paper? Send a correction.